Merck & Co., Inc.
Close on Oct 30, 2026Market cap $368.89BP/E 119.6Yield 2.19%
Merck Isentress / Isentress HD (raltegravir by Year
Isentress / Isentress HD (raltegravir — HIV-1 integrase inhibitor) — Worldwide constant-currency (ex-exchange) growth YoY (%) (%)
Merck Isentress / Isentress HD (raltegravir: -18.0% in FY2025, down 4.0 pts from a year earlier.
Where the FY2025 figure comes from
“|| Isentress/Isentress HD | 90 | 86 | 82 | 67 | 325 | 111 | 89 | 102 | 92 | 394 | -27 | -28 | -18 | -18”
Source: Form 8-K (tm264564d1_ex99-1.htm, filed 2026-02-03) ↗
Reported in Form 8-K Table 3 / 10-K / 10-Q MD&A.
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Isentress / Isentress HD (raltegravir — HIV-1 integrase inhibitor) — Worldwide constant-currency (ex-exchange) growth YoY (%) (%) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | -18.0% | -4.0 pts | Form 8-K (tm264564d1_ex99-1.htm, filed 2026-02-03) ↗ |
| FY2024 | Dec 31, 2024 | -14.0% | – | Form 8-K (tm255059d1_ex99-1.htm, filed 2025-02-04) ↗ |
Cite this data
StockData. (2026). Merck Isentress / Isentress HD (raltegravir (%), annual FY2024–FY2025 [Data set]. Compiled from Merck SEC filings and investor materials. https://stockdatahq.com/stocks/mrk/kpis/rev-isentress-ww-exfx-yoy
See every metric in the Merck KPI table. Data updated Oct 26, 2026.